[1] |
XIA Yao, ZHU Jiefu, SHI Lang, ZHA Hongchu, LI Huimin, HUANG Hua, YUE Ruchi, SONG Zhixia.
Kinase anchor protein 1 alleviates renal ischemia-reperfusion injury by inhibiting mitochondria division
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(2): 140-145.
|
[2] |
YU Beilei, JIANG Ling, LI Zhe, HU Zhen, GU Xiaoyan, GE Yongchun, GONG Dehua.
Effect of glomerular filtration rate on renal excretion fraction of solute and electrolyte in patients with acute and chronic kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(1): 1-7.
|
[3] |
XUE Xiang, LI Shijun.
Mechanisms of progression from acute kidney injury to chronic kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(1): 74-78.
|
[4] |
LIN Xiaohua, HUANG Qiongyi, CHEN Yuanhan.
Timing of initiating renal replacement therapy in critical patients with acute kidney injury
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(1): 79-83.
|
[5] |
XU Feng, ZENG Caihong.
IgA nephropathy with chronic calcineurin inhibitor nephrotoxicity after kidney transplantation
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(1): 90-94.
|
[6] |
.
Irisin plays a protective role in sepsis associated acute kidney injury by upregulating the expression of mitochondrial UCP2
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(6): 537-543.
|
[7] |
WEI Wei, YANG Letian, ZHAO Yuliang.
Progress on tubular epithelial tight junction in acute kidney injury
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(6): 567-572.
|
[8] |
.
Research progress of hypercalcemia-induced acute kidney injury
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(6): 585-589.
|
[9] |
WANG Yongfang, WANG Bin, WANG Xiaochun.
Resveratrol on contrast-associated acute kidney injury
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(4): 335-340.
|
[10] |
SHEN Ruihua, QIAO Xi.
Protective role of mitophagy in acute kidney injury
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(4): 363-367.
|
[11] |
ZHANG Lulu, XIA Wen, XU Feng, CHEN Duqun, JIN Ying, LIU Zhengzhao, ZENG Caihong, HU Weixin.
Risk factors and prognosis of acute kidney injury in patients with lupus podocytopathy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(3): 210-216.
|
[12] |
WEI Kaiyue, MI Yan, WANG Caili.
Hydroxychloroquine treatment in IgA nephropathy#br#
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(3): 266-271.
|
[13] |
WANG Chang, WANG Ruizhi, WU Gang.
Update on targeted treatment of IgA nephropathy#br#
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(3): 271-276.
|
[14] |
WU Bian, DONG Jianhua, LI Chuan, FAN Wenjing, HUANG Li, GE Yongchun.
Prognostic analysis of patients with posttraumatic acute kidney injury treated with continuous renal replacement therapy
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(2): 139-143.
|
[15] |
LI Jian, YANG Letian, ZHAO Yuliang.
NADPH oxidase 4 in acute kidney injury
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(2): 155-159.
|